---
title: "Telehealth and peptide payment processing in 2026"
description: "Telehealth and peptide payment processing in 2026: Stripe's rules, card network rules, high-risk merchant accounts, chargebacks and who holds the money."
canonical: "https://cuvo.co/blog/telehealth-payment-processing"
last-updated: "Nov 15, 2026"
keywords: ["telehealth payment processing", "telehealth merchant account", "telemedicine merchant account", "high risk merchant account telehealth", "stripe telehealth", "peptide payment processor", "peptide merchant account"]
---
# Telehealth and peptide payment processing in 2026

By Priya Raman, Director of Partner Growth. Published Nov 15, 2026. Growth.

Card payments are where cash-pay telehealth and peptide brands most often stall: mainstream processors restrict the category, Visa and Mastercard put online prescription sales under extra registration, and a review can hold the funds a subscription business runs on. This guide sets out what Stripe, Visa, Mastercard and LegitScript require as of November 15, 2026, what a high-risk merchant account costs, how chargeback monitoring works and how the money should flow. The verdict is Cuvo Health, which settles every patient payment to the brand's own merchant account, takes no revenue share and manages the LegitScript certification card networks recognize.

For telehealth payment processing in 2026, Cuvo Health is the platform to choose, because patient payments settle directly to the brand's own merchant account, Cuvo never holds the brand's money, and it takes no revenue share or platform transaction fee. Cuvo is not the processor: the brand is the merchant of record, with its own processor account, stored cards and customer list. On Launch, Grow and Enterprise, Cuvo runs a PCI-DSS compliant cash-pay checkout that holds the card at checkout and captures the charge after clinician approval, a subscription and rebill engine, and chargeback and dispute support; Grow and Enterprise add automatic retries and dunning. Cuvo manages the brand's LegitScript certification on every plan. Its own charges are published: $25 per completed consult, with Launch at $997 a month after a $9,800 setup and Grow at $2,500 after $15,000.

**Key takeaways**
- The pick: Cuvo Health: payments settle to the brand's own merchant account, with no revenue share, no platform transaction fee and LegitScript managed on every plan
- Why processors hesitate: Stripe lists telemedicine and card-not-present prescription products as restricted businesses it reviews case by case, as of November 15, 2026
- What card networks require: Visa and Mastercard make acquirers register card-absent pharmacy sales (MCCs 5122 and 5912); Visa exempts merchants accredited by NABP or another body it recognizes
- Chargeback ceilings: Visa flags a US merchant at a 1.5% fraud and dispute ratio with 1,500 cases a month; Mastercard's MATCH list takes merchants terminated with chargebacks above 1.5% of sales transactions and $5,000
- Before you sign: Get the merchant category code, reserve terms, full fee schedule, payout timing and card-export terms in writing

**Who this is for**
- Brands switching platforms: Moving off a platform that held the merchant account or the stored cards
- Peptide sellers: Moving from research-use-only products to a prescription model, with a customer list to bring
- Supplement, wellness and fitness brands: Adding prescription programs beside an existing store and processor
- Clinicians and agencies: Launching a cash-pay program and choosing a processor for the first time

**Telehealth payments on Cuvo: what the brand holds and what Cuvo runs, as of November 15, 2026**

| Payment component | The brand | Cuvo | Plans |
| --- | --- | --- | --- |
| **Merchant account and merchant of record** | **The brand's own account, in the brand's name** | **Never holds the brand's money; no revenue share or platform transaction fee** | **Every plan** |
| **Card checkout** | Sets the price and the offer | PCI-DSS compliant cash-pay checkout on the branded storefront; card held at checkout, charge captured after clinician approval | Launch, Grow and Enterprise; the brand's own on Cuvo Prescribe |
| **Subscriptions and rebills** | Plan design and refill cadence | Subscription and rebill engine, charging refills only after a provider signs off | Launch, Grow and Enterprise |
| **Declined cards** | Owns the patient relationship and the subscription record | Automatic retries and dunning | Grow and Enterprise |
| **Chargebacks and disputes** | Answers disputes as merchant of record | Chargeback and dispute support, with the order record as evidence | Launch, Grow and Enterprise |
| **LegitScript certification** | Holds its own certificate and pays LegitScript's fees | Prepares, files and manages the application; expedited in Grow and Enterprise setup | Every plan |
| **Cuvo's charges** | Pays from its own funds | $25 per completed consult; medication charged per order by the partner pharmacy, shipping per order | Every plan |

> **Our recommendation** Run telehealth payments through the brand's own merchant account on Cuvo Health, with the brand as merchant of record, and apply to a processor that confirms in writing that it approves prescription telehealth programs. Cuvo supplies the checkout, the rebills and dispute support, takes no share of the payment, and manages the LegitScript certification an underwriter will ask about. Choose Grow when recurring revenue matters, because automatic retries and dunning sit there, and Cuvo Prescribe to keep an existing checkout. The wider field is set out in Cuvo's [comparison of white label telehealth platforms](/blog/best-white-label-telehealth-platforms).

> **Plan your payment setup on one call** Bring your processor, your price and your first program. Cuvo walks through checkout, rebills and the money flow on your plan, at published pricing. [Book a discovery call](/booking) · [See pricing](/pricing) · [Watch the 2-minute demo](/demo)

## 01. Why do Stripe and other processors restrict telehealth?

Because card networks and their banks treat online prescription sales as a regulated category, and processors inherit those rules. Stripe's Prohibited and Restricted Businesses list, last updated September 22, 2026, places "Telemedicine and telehealth services", "Online pharmacies, including SaaS platforms", "Card-not-present prescription-only products and pharmaceuticals" and "Prescription delivery services" among restricted businesses, which "require additional due diligence by Stripe in order to confirm our ability to support them."

Restricted is not prohibited. Stripe's FAQ says it reviews each telemedicine business "on a case-by-case basis", that applicants typically provide items such as license numbers and information on their processes, and that telemedicine businesses do not need LegitScript certification to use Stripe. It also says pharmacies are approved only for merchants in the US, Canada, the EU, Australia, the UK and Japan. The caveat that matters most to a subscription business sits on the list itself: an approval "is specific to each service offer, and it may be modified or revoked by Stripe at any time".

Some mainstream rails are closed outright. Shopify Payments lists prescription drugs among its prohibited businesses and products, as read on November 15, 2026, so a Shopify store's built-in payments cannot take the prescription order; Cuvo's guide to [adding prescriptions to a Shopify store](/blog/ecommerce-telehealth-add-prescriptions-to-shopify) shows where the store ends and the clinic begins. The practical reading: a processor can work for telehealth once it has underwritten the specific program, and the approval covers the program described in the application, not whatever is added to the menu later.

## 02. What do Visa and Mastercard require of telehealth merchants?

Registration, monitoring and proof of legality. Visa's Merchant Data Standards Manual (October 2026) lists card-absent sales under MCC 5122 (drugs, drug proprietaries and druggist sundries) and MCC 5912 (drug stores and pharmacies) among its high integrity risk merchant category codes. Under the Visa Core Rules of October 24, 2026, an acquirer must be approved by Visa and must register these merchants before submitting their transactions, unless the merchant is accredited by the National Association of Boards of Pharmacy (NABP) "or other regulatory body recognized by Visa".

Mastercard's Security Rules and Procedures, in the August 4, 2026 edition, require an acquirer to register a merchant with Mastercard before acquiring non-face-to-face pharmaceutical transactions under the same two codes. At registration the acquirer must have verified that the merchant's activity complies fully with applicable law, which may rest on "a written opinion from independent, reputable, and qualified legal counsel or accreditation by a recognized third party", and it must confirm continued compliance at least every 12 months.

**Card network rules for online prescription sales, as of November 15, 2026**

| Rule | Visa | Mastercard |
| --- | --- | --- |
| **Codes covered** | MCC 5122 and 5912, card-absent sales | MCC 5122 and 5912, non-face-to-face sales |
| **Registration** | Acquirer approved by Visa; merchant registered before transactions | Merchant registered with Mastercard before acquiring |
| **Proof of legitimacy** | No registration needed if accredited by NABP or another body Visa recognizes | Legal opinion or accreditation by a recognized third party, reconfirmed every 12 months |
| **Ongoing monitoring** | Daily review of sales, ticket size and disputes from day 31 | Excessive Chargeback Program, measured in basis points |
| **Repeat problems** | Visa may disqualify a merchant at a critical level of disputes | A terminated merchant can be listed on MATCH Pro |

Which code applies is the acquirer's call. Visa describes 5912 merchants as those that "sell prescription and proprietary drugs", while 8099 covers medical professionals not classified with a more specific code. Ask which code the acquirer will assign before signing, because the code decides which registration applies. LegitScript states that "Visa and Mastercard recognize LegitScript Certification, helping you get faster approval for card-not-present transactions."

## 03. What is a high-risk telehealth merchant account?

A telehealth merchant account, which processors also call a telemedicine merchant account, is the account with an acquiring bank that lets a brand take card payments for prescription programs in its own name. Calling it a high-risk merchant account means it is underwritten, priced and watched as a category with more regulation and more disputes, not that the business is doing anything wrong. Expect an application for a prescription program to cover more than a retail one: the company and its owners, the professional entity and provider licensing, the pharmacy relationships, the website with its terms, refund policy and prices, and often certification. Mastercard's MATCH Pro database records up to five principal owners alongside each listed business, so the people behind an account are part of the file.

Monitoring is continuous. For a Visa high integrity risk merchant, the acquirer must keep daily gross sales volume, average transaction amount, number of transaction receipts and number of disputes, set the merchant's normal daily activity from its first month, and compare current activity against it at least daily from the 31st day after the first deposit. A sharp jump in volume after a successful campaign can trigger the same review as a problem, so tell the processor before scaling ad spend.

Reserves are the other feature. Stripe defines a reserve as "a temporary hold on a portion of a business's funds for a predetermined period of time", sized to the risk of the business so funds cover future disputes and refunds. A fixed reserve holds a set percentage of each new transaction until a release date; a rolling reserve holds it on a rolling basis. A reserve is not a fee, but it delays cash, so get its percentage, duration and release terms into the merchant agreement.

## 04. Who is the merchant of record, and why does it matter?

The merchant of record is the business that sells in its own name and takes the payment through its own merchant account, so its name appears on the card statement and it answers for refunds and chargebacks; Cuvo's glossary defines the [merchant of record](/glossary/merchant-of-record) in full. On a telehealth platform either the brand holds that role or the platform does, and the difference decides who is paid first, who controls refunds and disputes, and who keeps the saved cards.

When the platform is merchant of record, patients pay into the platform's account and the brand waits for a payout, sometimes net of a revenue share. The cards on file and the subscription records sit in an account the brand does not control, so changing platforms can mean asking every patient to enter a card again. When the brand is merchant of record, money lands in its own account first and the stored cards stay with it. Cuvo's guide to [who owns the patients and data](/blog/who-owns-the-patients-and-data-on-a-white-label-telehealth-platform) covers the exit side.

Buyers often ask whether they would run on their own Stripe account or inside a platform's master account. On Cuvo it is the brand's own: the brand connects its own Stripe account or another supported merchant account in the console's payment settings, there is no master account holding patient payments, and Cuvo never holds the money. Whether a specific existing gateway connects is confirmed on the discovery call.

## 05. What does telehealth payment processing cost?

Four costs make up the bill: the card networks' interchange and fees, the processor's own margin, event fees such as disputes, and the cash held in any reserve. Visa describes interchange as a transfer fee between the acquiring bank and the card-issuing bank, and the merchant pays its acquirer or processor a merchant discount, usually a percentage of each transaction. On flat-rate pricing one number bundles everything; on interchange-plus pricing the processor shows the interchange it pays and its own margin separately.

**Card processing cost components, with Stripe's published standard rates as of November 15, 2026**

| Cost | Who sets it | How it is charged | Published example |
| --- | --- | --- | --- |
| **Interchange and network fees** | Visa and Mastercard; interchange passes from the acquiring bank to the issuing bank | Recovered through the merchant discount; varies by card type | Shown separately on interchange-plus statements |
| **Processor rate** | The processor | A flat rate, or a margin over interchange | Stripe standard: 2.9% plus 30 cents per successful domestic card transaction |
| **Rate adders** | The processor | Added for certain cards | Stripe: 0.5% for manually entered cards, 1.5% for international cards, 1% when currency conversion is required |
| **Dispute fees** | The processor | Per chargeback received or contested | Stripe: $15 per dispute received, and $15 to counter one, returned if the dispute is won |
| **Reserve** | The processor, at underwriting | A share of each transaction held, fixed or rolling | Set per business; a cash-flow cost, not a fee |
| **Platform share** | The telehealth platform | A revenue share or transaction fee on some platforms | **Cuvo: none; $25 per completed consult** |

As an example at Stripe's published standard rate, a $299 monthly order costs $8.97 to process (2.9% of $299 plus 30 cents), every month the patient renews. Cuvo's guide to [pricing a telehealth subscription](/blog/pricing-telehealth-subscriptions) carries that line through a full program budget.

A processor that underwrites a telehealth program individually quotes after underwriting, so compare offers on the effective rate, total processing fees divided by volume, and read the schedule for monthly, gateway, retrieval and early termination fees. Stripe lists interchange-plus pricing and volume discounts under its custom packages for businesses with large payment volume or unique business models. On Cuvo, nothing is added on top: no platform transaction fee and no revenue share.

> **See the money flow on your plan** Cuvo maps checkout, rebills, failed-payment recovery and its own invoice lines against your program and your processor. [Book a discovery call](/booking) · [See retention tools](/retention) · [Watch the 2-minute demo](/demo)

## 06. How do chargebacks and card network monitoring work?

A chargeback reverses a card payment when the cardholder's bank upholds a dispute, and the merchant of record returns the amount and pays the processor's dispute fee. Card networks track the rate for every merchant and every acquirer. Visa's Acquirer Monitoring Program (VAMP) counts fraud reports and disputes on card-not-present transactions against settled transactions. Since April 1, 2026, a US merchant is Excessive at a ratio of 150 basis points (1.5%) with at least 1,500 fraud reports and disputes in the month.

Acquirers are measured on the same ratio across their whole portfolio, Above Standard at 50 basis points and Excessive at 70, which gives them reason to act on a merchant's rate long before it reaches the merchant tier. The ratio excludes disputes resolved through pre-dispute solutions, so ask which dispute alerts and early resolution tools the processor includes.

Mastercard's Excessive Chargeback Program measures a merchant's chargebacks in a calendar month against its Mastercard transactions in the preceding month, in basis points, and classes merchants as Excessive or High Excessive Chargeback Merchants against thresholds in a manual Mastercard issues to member banks. The lasting consequence is MATCH Pro, the database of terminated merchants that Mastercard requires acquirers to report to and check: a merchant terminated after its chargebacks over the previous three months exceeded 1.5% of its Mastercard sales transactions and totaled at least $5,000 goes in under reason code 04. A listed merchant can still be onboarded, but any acquirer that checks will see the entry.

Two habits keep the rate down. Hold the card at checkout and capture only after the provider approves, so a patient who is not prescribed is never charged and never refunded; Visa allows up to 10 calendar days between approval and processing for a card-absent purchase. And keep the evidence: on Cuvo the order record holds the intake and consents, identity verification, the clinician's decision, the shipment's carrier and tracking, and for memberships the patient's auto-renew consent and every renewal email. Never spread volume across accounts to dilute a ratio: Visa may disqualify a high integrity risk merchant that acts with intent to circumvent its programs.

## 07. How do subscription rebills and failed payments work?

A program that bills monthly is a recurring transaction under card rules, and those rules are specific. Under the Visa Core Rules of October 24, 2026, a merchant must offer a simple cancellation procedure, online if the order was taken online, state the fixed dates or intervals of the charges, and, at least 7 days before a charge that follows a trial, introductory offer or promotional period, notify the cardholder with the amount, the date and a simple way to cancel. Federal law adds its own duties under the Restore Online Shoppers' Confidence Act: disclose all material terms before taking billing information, get express informed consent before charging, and provide a simple way to stop recurring charges. Cuvo's guide to [FTC rules for telehealth subscriptions](/blog/ftc-rules-for-telehealth-subscriptions-and-health-ads) covers them in depth.

Failed payments are the quieter loss. Recurly estimates that involuntary churn, subscriptions lost to failed payments, accounts for 20% to 40% of total churn across subscription businesses; in one enterprise retailer's data, optimized retries lifted recovery of failed transactions from about 53% to about 71%, with 90% of recoveries in the first 10 days (April 30, 2026). Ask whether the processor uses card updater services such as Visa Account Updater, which Visa's rules require US card issuers to enroll their card ranges in.

On Cuvo, the subscription and rebill engine re-bills and re-ships automatically on Launch, Grow and Enterprise, and a refill is charged only after a provider signs off on it. On Grow and Enterprise, failed payment recovery retries a declined card automatically and runs dunning. In the console, a first order whose payment fails waits until the patient saves a new card, with the reminders tracked on the order, and a declined membership renewal shows as past due while it is retried. Cuvo's [retention tools](/retention) cover the refill journey around the charge.

## 08. Does LegitScript certification help with payment processing?

It helps underwriting and it is required for advertising, but it is not a payment approval. LegitScript says Visa and Mastercard recognize its certification for faster card-not-present approval, and lists protection "from merchant account freezes, payment holds, or shutdowns caused by healthcare compliance issues" among the reasons telemedicine providers certify. That lines up with the network rules: Visa's registration exemption for accredited pharmacy merchants, and Mastercard's acceptance of accreditation by a recognized third party as proof of legality.

Two limits apply. Stripe says telemedicine businesses do not need LegitScript certification to use Stripe, so certification is one input to underwriting rather than a universal requirement. And LegitScript's own November 2, 2026 guidance says "certification does not guarantee access to their services", meaning payment providers and ad platforms, which set their own policies. Advertising is where it is mandatory: Google and Meta require LegitScript certification before a US telehealth brand can advertise prescription treatment, as Cuvo's [LegitScript guide for Meta and Google ads](/blog/legitscript-certification-for-meta-and-google-ads) explains.

On Cuvo, the brand's LegitScript certification is prepared, filed and managed on every plan and expedited in the Grow and Enterprise setup, and recent Cuvo brand applications averaged 7 to 14 days to approval. LegitScript certifies the entity that advertises, so the brand holds its own certificate and pays LegitScript's application and annual fees, $975 per website to apply and $2,150 a year per website as of November 15, 2026. Cuvo's own site, cuvo.co, is LegitScript certified.

## 09. Peptide payment processors: how to get a merchant account

A peptide payment processor approves the business it can describe to its bank, so a peptide merchant account goes to a brand that sells peptides the way processors and card networks already understand them: as prescriptions from a licensed provider, filled by a licensed pharmacy. Stripe's FAQ says "a large number of peptides are prescription only and are required to be sold by pharmacies, meaning Stripe must preapprove the merchant", and that it will "assume that peptides sold where no purpose is specified are sold for human consumption." Stripe allows research-purpose peptides only with measures that keep them from buyers who would use them for anything else, so a consumer brand cannot rely on a research-use-only label.

For a seller moving from research-use-only products, the new merchant application describes a different business: prescription telehealth with pharmacy fulfillment, which Stripe reviews before approval and which Visa and Mastercard register when it is coded as a pharmacy sale. LegitScript's November 2, 2026 update says offering one of the six peptides in HHS's October 28, 2026 enforcement discretion policy, BPC-157, TB-500, MOTS-c, KPV, Semax and Epitalon, should not by itself prevent certification when the offering meets the policy's conditions, while other peptides outside the policy remain a barrier. Certification still does not guarantee payment approval.

On Cuvo, the six are offered through Cuvo's 503A partner pharmacy, each only in its covered form and routes, as a single-ingredient prescription a licensed provider decides on. Cuvo never sells blends or stacks, pens or auto-injectors, or research-use products. Payments settle to the brand's own merchant account like every other program, and Cuvo's [HHS peptide policy guide](/blog/hhs-peptide-policy-bpc-157) sets out the rules in full.

## 10. How do payments and money flow work on Cuvo?

The patient pays the brand, and the brand pays Cuvo. Patient payments settle directly to the brand's own merchant account, Cuvo never holds the brand's money, and Cuvo takes no revenue share and adds no platform transaction fee to the checkout. The brand keeps what patients pay, minus standard card processing, and pays Cuvo's published charges from its own funds.

**How money moves on Cuvo, step by step**

| Step | What happens to the money | Whose account | Who decides |
| --- | --- | --- | --- |
| **1. Checkout** | The card is held for the order on the brand's storefront; nothing is captured yet | The brand's merchant account | The patient |
| **2. Clinician review** | Approved: the charge is captured. Not approved: nothing is captured | The brand's merchant account | A licensed provider |
| **3. Settlement** | The processor pays out to the brand's business bank account, less its fees and any reserve | The brand's processor and bank | The processor's payout schedule |
| **4. Cuvo's charges** | $25 per completed consult; medication charged per order by the partner pharmacy, with shipping per order | Paid by the brand | Published pricing, itemized by case |
| **5. Refills and renewals** | The rebill engine charges the stored card after the provider authorizes the refill; Grow and Enterprise retry declines | The brand's merchant account | The provider, then the patient's card |
| **6. Affiliate partners** | Cuvo builds the payout list; the brand pays partners its own way, and refunds reverse commissions | The brand's own payout method | The brand's program rules |

Cuvo's charges are itemized: each billable clinical event is recorded against its case, and on Grow, Enterprise and Cuvo Prescribe the Integrations API exposes usage, invoices and invoice lines for the finance team. The brand owns the patient relationship, the customer list and every business record, including orders, subscriptions, invoices and revenue, exportable at any time; medical charts belong to the treating professional corporation and its licensed clinicians, as the law requires.

On Cuvo Prescribe, for a company keeping its existing stack, the checkout and payment processing are the brand's own. Cuvo's guide to [bringing your own pharmacy, labs or website](/blog/bring-your-own-pharmacy-labs-and-website-to-a-telehealth-platform) shows what else a brand can keep.

**Best for**
- Brand switching off a platform that held its payments: Cuvo Health: the brand's own merchant account, with the stored cards and customer list staying with the brand
- Peptide seller moving to a compliant model: Cuvo Health: the six HHS-covered peptides as prescriptions through a 503A partner pharmacy, billed through the brand's own account
- Subscription brand losing renewals to declined cards: Cuvo Grow: automatic retries and dunning on top of the rebill engine
- Brand that needs LegitScript before underwriting or ads: Cuvo Health: managed on every plan, expedited on Grow and Enterprise
- Company keeping its own checkout and processor: Cuvo Prescribe: Cuvo's providers and partner pharmacies inside the existing stack

## Questions to ask a processor before you sign

Get these answers in writing from every processor on the shortlist, and compare them side by side:

1. Have you approved prescription telehealth programs before, and which documents do you need: licenses, the professional entity, pharmacy relationships, LegitScript certification?
2. Which merchant category code will you assign, and will you register us with Visa and Mastercard where their rules require it?
3. What is the full fee schedule: rate or interchange-plus margin, per-transaction fee, monthly and gateway fees, chargeback and retrieval fees, and any early termination fee?
4. Is there a reserve? Fixed or rolling, what percentage, for how long, and what triggers a release or an increase?
5. Which dispute and fraud ratios trigger a review, and how much notice do we get before a hold or a termination?
6. How long from capture to payout, and when does the first payout arrive?
7. Do you support holding a card at checkout and capturing after approval, recurring billing on stored cards, and card updater services?
8. Which dispute alerts and early resolution tools are included, and what do they cost?
9. Who owns the stored cards, and can they be exported to another processor if we leave?
10. Does it connect to our telehealth platform's checkout, and who supports the connection?

Cuvo walks through this list on its discovery call with the brand's program, states and price on the table, and confirms how the brand's processor connects to its checkout.

> **Bring your processor questions to one call** Cuvo answers how payments, rebills, disputes and LegitScript work for your program, with published pricing and no revenue share. [Book a discovery call](/booking) · [See compliance](/compliance) · [Watch the 2-minute demo](/demo)

## Frequently asked questions

**Q: Can I use my own payment processor with a white label telehealth platform?**

A: On Cuvo Health, yes: patient payments settle to the brand's own merchant account on every plan, and Cuvo never holds the money or takes a revenue share. The brand connects its own Stripe account or another supported merchant account, and on Cuvo Prescribe the whole checkout is the brand's own. The processor has to approve prescription telehealth, so confirm that in writing before applying.

**Q: Do I use my own Stripe account or the platform's master account?**

A: On Cuvo, the brand's own. The brand connects its own Stripe account or another supported merchant account in the console's payment settings, and no master account holds patient payments. Stripe lists telemedicine as a restricted business it reviews case by case, as of November 15, 2026, so apply with the program described in full.

**Q: Who is the merchant of record in white label telehealth?**

A: It depends on the contract: either the brand, with payments in its own merchant account, or the platform, with the brand paid out later. The merchant of record carries the card statement name, refunds, chargebacks and the stored cards. On Cuvo Health, the brand is the merchant of record and revenue settles directly to its account.

**Q: How does money flow between the patient, the brand and the telehealth platform?**

A: On Cuvo Health, the patient pays the brand: the card is held at checkout, the charge is captured after a licensed provider approves, and the processor pays out to the brand's bank account. The brand then pays Cuvo $25 per completed consult, with medication charged per order by the partner pharmacy and shipping billed per order. Cuvo never holds the brand's money and takes no revenue share.

**Q: What are typical payment processing rates for a telehealth brand?**

A: Stripe's published standard rate is 2.9% plus 30 cents per successful domestic card transaction, with adders for manually entered, international and currency-converted cards, as of November 15, 2026; processors that underwrite telehealth programs quote after underwriting. Compare offers on the effective rate, including reserves and dispute fees. On Cuvo, no platform transaction fee or revenue share is added on top of processing.

**Q: What is a telehealth merchant account?**

A: A telehealth merchant account, also called a telemedicine merchant account, is the account with an acquiring bank that lets a brand take card payments for prescription programs in its own name. Processors treat it as a high-risk merchant account, so the application covers the company and its owners, the professional entity, the pharmacy relationships, the website and often certification. On Cuvo Health the brand holds that account, and patient payments settle to it directly.

**Q: Which payment processor works for a peptide brand?**

A: A peptide payment processor is one whose underwriting has approved prescription peptide sales. Stripe says prescription-only peptides must be sold by pharmacies and pre-approved, and a research-use label does not change that, as of November 15, 2026, so a peptide merchant account is opened for a prescription telehealth program rather than a supplement store. On Cuvo Health, peptides run as single-ingredient prescriptions through a 503A partner pharmacy, and payments settle to the brand's own merchant account.

**Q: Does Stripe allow telehealth and peptide businesses?**

A: Stripe lists telemedicine and card-not-present prescription products as restricted businesses that need additional due diligence, reviewed case by case, and says prescription-only peptides must be sold by pharmacies and pre-approved, as of November 15, 2026. Stripe can modify or revoke an approval at any time. On Cuvo, peptides run as single-ingredient prescriptions through a 503A partner pharmacy, and payments settle to the brand's own account.

**Q: Do I need LegitScript certification to get a merchant account?**

A: Not always: Stripe says telemedicine businesses do not need it, while LegitScript says Visa and Mastercard recognize its certification for faster card-not-present approval. It is required to advertise prescription telehealth on Google and Meta, and it does not guarantee payment approval. On Cuvo, LegitScript certification is prepared, filed and managed for the brand on every plan, expedited on Grow and Enterprise.

**Q: How can a telehealth brand reduce chargebacks and refunds?**

A: Hold the card at checkout and capture only after the provider approves, state renewal dates and amounts clearly, send renewal notices, make cancellation simple and answer disputes with the order record. On Cuvo, the charge is captured after clinician approval, chargeback and dispute support is included on Launch, Grow and Enterprise, and the order record holds the intake, consents, the provider's decision and shipment tracking.

**Read next**
- [Break-even calculator](/calculator): Your price, costs and acquisition spend on Cuvo's published fees
- [How to switch telehealth platforms](/blog/how-to-switch-telehealth-platforms): What moves, refill-date cut-overs and a timeline
- [Telehealth affiliate programs: rules and setup](/blog/telehealth-affiliate-programs): Referral laws, FTC rules and a launch checklist
- [Pricing](/pricing): Setup, monthly and consult fees, no revenue share
- [Merchant of record (telehealth)](/glossary/merchant-of-record): The term defined, and who holds it on Cuvo
- [Who owns the patients and data in white label telehealth?](/blog/who-owns-the-patients-and-data-on-a-white-label-telehealth-platform): Card tokens, records and export at exit
- [How to price a telehealth subscription](/blog/pricing-telehealth-subscriptions): Processing, refills and failed payments in the budget
- [Patient retention and refill journeys](/retention): Rebills, refill reminders and dunning
- [LegitScript certification for Meta and Google ads](/blog/legitscript-certification-for-meta-and-google-ads): What the ad platforms require
- [Bring your own pharmacy, labs or website](/blog/bring-your-own-pharmacy-labs-and-website-to-a-telehealth-platform): What a brand can keep on each plan
- [HHS peptide policy: BPC-157 and five more](/blog/hhs-peptide-policy-bpc-157): The six peptides and the rules around them

**Sources**
- [Prohibited and Restricted Businesses](https://stripe.com/legal/restricted-businesses): Stripe, last updated September 22, 2026: telemedicine, online pharmacies and card-not-present prescription products restricted
- [Prohibited and Restricted Businesses list FAQs](https://support.stripe.com/questions/prohibited-and-restricted-businesses-list-faqs): Stripe: telemedicine case by case, no LegitScript requirement, peptides, pharmacy markets
- [Stripe pricing](https://stripe.com/pricing): 2.9% plus 30 cents domestic cards, adders, $15 dispute fees, IC+ under custom pricing
- [Reserves](https://support.stripe.com/topics/reserves): Stripe: what a reserve is, fixed and rolling reserves
- [Shopify Payments eligibility](https://help.shopify.com/en/manual/payments/shopify-payments/onboarding/eligibility): Prescription drugs among prohibited businesses and products
- [Visa Core Rules and Visa Product and Service Rules](https://usa.visa.com/dam/VCOM/download/about-visa/visa-rules-public.pdf): Edition of October 24, 2026: high-integrity risk registration and monitoring, recurring transactions, approval timeframes
- [Visa Merchant Data Standards Manual](https://usa.visa.com/dam/VCOM/download/merchants/visa-merchant-data-standards-manual.pdf): October 2026: high integrity risk MCCs 5122 and 5912; MCC 8099
- [Visa Acquirer Monitoring Program fact sheet](https://corporate.visa.com/content/dam/VCOM/corporate/visa-perspectives/security-and-trust/documents/visa-acquirer-monitoring-program-fact-sheet-2025.pdf): VAMP ratio and thresholds; US merchant threshold 150 basis points from April 1, 2026
- [Visa: interchange and regulation fees](https://www.visa.com/en-us/support/business/regulation-fees): Interchange as a transfer between acquiring and issuing banks; the merchant discount
- [Mastercard Security Rules and Procedures, Merchant Edition](https://www.mastercard.com/content/dam/mccom/shared/business/support/rules-pdfs/SPME-Manual.pdf): August 4, 2026: pharmaceutical merchant registration, Excessive Chargeback Program, MATCH Pro reason codes
- [Healthcare certification](https://www.legitscript.com/certification/healthcare-certification/): LegitScript: Visa and Mastercard recognition, $975 application, $2,150 a year per website
- [HHS's peptide compounding policy: what healthcare businesses need to know](https://www.legitscript.com/healthcare/hhs-peptide-compounding-policy-what-healthcare-businesses-need-to-know/): LegitScript, November 2, 2026: certification does not guarantee payment or ad access
- [LegitScript website lookup: cuvo.co](https://www.legitscript.com/websites/?checker_keywords=cuvo.co): Cuvo's own certification
- [15 U.S.C. 8403: Restore Online Shoppers' Confidence Act](https://www.law.cornell.edu/uscode/text/15/8403): Disclosure, express informed consent and a simple way to stop recurring charges
- [Failed payment recovery: a data-based strategy](https://recurly.com/blog/failed-payment-recovery-data-based-strategy/): Recurly, April 30, 2026: involuntary churn and retry recovery data

*General information only: This guide is general information for brand owners and operators, not legal, financial or tax advice. Processor policies, card network rules, LegitScript terms and fees are described as read on November 15, 2026 and change often; the merchant agreement and the acquirer's current requirements govern. No processor, card network or certification body promises approval, and Cuvo makes no representation about approval, processing rates or revenue. Every clinical decision, including prescribing and refills, rests with the treating licensed provider, and licensed pharmacies dispense.*

**Terms in this guide**
- [Merchant of record (telehealth)](/glossary/merchant-of-record)
- [Research use only (RUO) products](/glossary/research-use-only)
- [LegitScript certification](/glossary/legitscript-certification)
- [Restore Online Shoppers' Confidence Act (ROSCA)](/glossary/restore-online-shoppers-confidence-act)
- [Revenue share (telehealth platforms)](/glossary/telehealth-platform-revenue-share)
- [Professional corporation (PC) and PLLC](/glossary/professional-corporation)

Canonical page: https://cuvo.co/blog/telehealth-payment-processing
